Form 4: Beta Bionics CFO Sells Shares for Tax Obligations

Beta Bionics' Chief Financial Officer, Stephen Feider, sold 1,462 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Stephen Feider, Chief Financial Officer of Beta Bionics, Inc. (BBNX), reported a sale of common stock.
• The transaction involved 1,462 shares of common stock.
• The shares were sold at a weighted average price of $18.8632 per share, with prices ranging from $18.58 to $19.09.
• The sale occurred on September 2, 2025.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Feider directly beneficially owns 44,041 shares of common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (sale to cover tax obligations) which is a common practice and generally considered neutral in terms of company sentiment.

Future Outlook

N/A. This filing does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
• The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09.

Industry Context

N/A. This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, tax-related sale by an executive, not indicative of a change in company fundamentals or management's long-term view.

Key Dates

Keywords

Beta Bionics, BBNX, Stephen Feider, Chief Financial Officer, CFO, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation